dr. johnson on the limitations of biomarkers in melanoma
Published 3 years ago • 83 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
0:51
dr. johnson on the need for novel biomarkers in melanoma
-
7:48
the current understanding of biomarkers in melanoma
-
1:34
dr. johnson on applications of immunotherapy in melanoma
-
0:49
dr. polsky on the exploration of blood-based biomarkers in melanoma
-
2:00
dr. blank on predictive biomarkers in macroscopic stage iii melanoma
-
1:57
yardena samuels on rasa2 as prognostic biomarker in melanoma
-
1:15
dr. hamid on tmb as a biomarker for immunotherapy response in melanoma
-
2:58
the importance of biomarkers to optimize treatment with immunotherapy for melanoma
-
1:13
dr. saenger on biomarkers for immunotherapy
-
1:19
beyond tissue biopsies: liquid biomarkers in melanoma
-
1:04
melanoma advances: where we are and where we're going
-
25:41
new immunotherapies, precision medicine and biomarkers in melanoma
-
0:55
the importance of biomarkers in treating melanoma patients
-
6:27
hot versus cold tumors: predictive markers in melanoma
-
4:25
the phenomenon of immunotherapy in melanoma
-
1:06
evaluating the suitability of checkpoint inhibitors with biomarkers in patients with melanoma
-
20:35
dr rebecca lee talks about biomarkers at melanoma patient conference 2022
-
40:35
biomarkers lighting the way
-
2:13
novel biomarkers in the early diagnosis of malignant melanoma, j. peña-martín et al.